Screener
Aquestive Therapeutics, Inc. AQST Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The source filing: Aquestive Therapeutics, Inc.’s 10-Q, filed August 11, 2026.
- Filed
- Aug 11, 2026, 4:10 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001398733-26-000042
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Prepaid expenses and other current assets | 3,312 | 4,168 |
| Total current assets | 118,494 | 149,269 |
| Property and equipment, net | 3,960 | 3,893 |
| Right-of-use assets, net | 7,949 | 4,621 |
| Other non-current assets | 1,701 | 2,642 |
| Total assets | $132,104 | $160,425 |
| Liabilities and stockholders’ deficit | ||
| Current liabilities: |
Item 1. FINANCIAL STATEMENTS (Unaudited)
FAQ
- What is Aquestive Therapeutics, Inc.'s operating lease ROU assets?
- Aquestive Therapeutics, Inc. (AQST) reported operating lease ROU assets of $7.95M in Q2 2026.
- How has Aquestive Therapeutics, Inc.'s operating lease ROU assets changed year-over-year?
- Aquestive Therapeutics, Inc.'s operating lease ROU assets increased by 61.9% year-over-year, from $4.91M to $7.95M.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s operating lease ROU assets?
- Over 5 years (2020 to 2025), Aquestive Therapeutics, Inc.'s operating lease ROU assets has grown at a 6.0% compound annual growth rate (CAGR), from $3.45M to $4.62M.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.
Ask your AI about Aquestive Therapeutics, Inc.'s operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude